These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32234429)

  • 1. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells.
    Al-Harbi NO; Nadeem A; Ahmad SF; Bakheet SA; El-Sherbeeny AM; Ibrahim KE; Alzahrani KS; Al-Harbi MM; Mahmood HM; Alqahtani F; Attia SM; Alotaibi MR
    Eur J Pharmacol; 2020 Jun; 877():173088. PubMed ID: 32234429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bruton's tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; Alanazi WA; Mahmood HM; Alsanea S; Attia SM
    Int Immunopharmacol; 2021 Jan; 90():107123. PubMed ID: 33168411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis.
    Alzahrani KS; Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; El-Sherbeeny AM; Alhoshani AR; Alshammari MA; Alotaibi MR; Al-Harbi MM
    Biomed Pharmacother; 2019 Mar; 111():347-358. PubMed ID: 30593001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod mouse model.
    Al-Harbi NO; Ahmad SF; Almutairi M; Alanazi AZ; Ibrahim KE; Alqarni SA; Alqahtani F; Alhazzani K; Alharbi M; Alasmari F; Nadeem A
    Cell Immunol; 2022 Jun; 376():104531. PubMed ID: 35576719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms.
    Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C
    Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
    Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
    Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
    Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R
    Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation.
    Jin L; Dong L; Pei S; Chen X; Kuang Y; Chen W; Zhu W; Yin M
    Eur J Pharmacol; 2024 Apr; 968():176382. PubMed ID: 38311277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
    Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
    Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Emerging Role of
    Yang Y; Zhao Y; Lai R; Xian L; Lei Q; Xu J; Guo M; Xian D; Zhong J
    Oxid Med Cell Longev; 2022; 2022():5800586. PubMed ID: 35720176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bruton's tyrosine kinase drives neuroinflammation and anxiogenic behavior in mouse models of stress.
    Ghosh S; Mohammed Z; Singh I
    J Neuroinflammation; 2021 Dec; 18(1):289. PubMed ID: 34895246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice.
    Deng G; Chen W; Wang P; Zhan T; Zheng W; Gu Z; Wang X; Ji X; Sun Y
    Int Immunopharmacol; 2019 Sep; 74():105682. PubMed ID: 31203155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.